STAT3 and neoplasm: Thus, our data suggests that genetic depletion of STAT3 in HStCs is sufficient to inhibit myMAF activation and is associated with an improved immunostimulatory anti-tumour response in PDAC liver metastasis (Fig. 8D–F).